Home / Digestive tract and metabolism / Insulin Aspart
ATC A10AD05 · Insulins and Analogues for Injection, Intermediate- Or Long-Acting Combined with Fast-Acting · updated 4 Nov 2026
Insulin Aspart shortage
As of 4 Nov 2026, Insulin Aspart has a reported shortage in 1 of the 16 countries we track (Japan), covering 1 product from 1 company.
Is there an Insulin Aspart shortage?
Yes. As of 4 Nov 2026, Insulin Aspart is reported short in 1 of the 16 countries we track: Japan. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Novo Nordisk NOVO B · Nasdaq Copenhagen
Compared with similar medicines
ATC group A10AD · Insulins and Analogues for Injection, Intermediate- Or Long-Acting Combined with Fast-ActingAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | ノボラピッド注 フレックスタッチ | Novo Nordisk | 24 May 2024 | not given | Other |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Insulin Aspart shortage?
Yes. As of 4 Nov 2026, Insulin Aspart is reported short in 1 of the 16 countries we track: Japan. No company has given a return date.
When will Insulin Aspart be back in stock?
No return date has been given; Japan: no date given. These are company estimates reported to each authority.
Why is Insulin Aspart in short supply?
The most common reason reported is: other. Reasons by product are listed in the table below.
Which companies have Insulin Aspart shortages?
Novo Nordisk.